Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
Holding SPRO?
Track your performance easily

Spero Therapeutics (SPRO) Income Statement

499 Followers

Spero Therapeutics Income Statement

Last quarter (Q2 2024), Spero Therapeutics's total revenue was $10.20M, an increase of 275.44% from the same quarter last year. In Q2, Spero Therapeutics's net income was $-17.86M. See Spero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 116.76M$ 96.73M$ 53.51M$ 18.26M$ 9.33M$ 18.15M
Cost of Revenue
------
Gross Profit
$ 118.46M$ 103.78M$ 53.51M$ 18.26M--
Operating Expense
$ 102.91M$ 69.95M$ 95.71M$ 106.23M$ 88.44M$ 81.36M
Operating Income
$ 15.55M$ 21.48M$ -42.20M$ -87.97M$ -79.11M$ -63.22M
Net Non Operating Interest Income Expense
$ 4.52M$ 3.94M$ 1.11M$ -1.59M$ 401.00K$ 1.33M
Other Income Expense
$ 19.00K$ -5.32M$ 5.32M$ 191.00K$ 432.00K$ 963.00K
Pretax Income
$ 843.00K$ 25.40M$ -46.41M$ -89.76M$ -78.28M$ -60.92M
Tax Provision
$ 2.59M$ 2.60M----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 17.47M$ 22.81M$ -46.41M$ -89.76M$ -78.28M$ -60.92M
Basic EPS
$ 0.34$ 0.43$ -1.23$ -2.91$ -3.52$ -3.35
Diluted EPS
$ 0.32$ 0.43$ -1.23$ -2.91$ -3.52$ -3.35
Basic Average Shares
$ 213.20M$ 52.70M$ 37.59M$ 30.90M$ 22.39M$ 18.16M
Diluted Average Shares
$ 214.34M$ 52.99M$ 37.59M$ 30.90M$ 22.39M$ 18.16M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 102.91M$ 69.95M$ 95.71M$ 106.23M$ 88.44M$ 81.36M
Net Income From Continuing And Discontinued Operation
$ 17.45M$ 22.81M$ -46.41M$ -89.76M$ -78.28M$ -60.92M
Normalized Income
$ -3.98M$ 25.38M$ -15.80M-$ -78.28M$ -61.15M
Interest Expense
----$ 0.00-
EBIT
$ 10.93M$ 25.40M$ -46.41M$ -88.16M$ -78.28M$ -63.22M
EBITDA
$ 11.07M$ 25.77M$ -45.53M$ -87.27M$ -77.52M$ -62.47M
Currency in USD

Spero Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis